Teewinot Life Sciences Corporation is an international biopharmaceutical company focused on the use of synthetic biology and advanced formulation for the production and implementation of cannabinoid based therapies. With headquarters in Tampa, Florida, and wholly owned subsidiaries in Canada and Ireland, Teewinot manufactures and licenses technology to make cost effective, pharmaceutically pure, authentic cannabinoids, prodrugs, and analogs as an industry leader in support of advancing medical research and product development. Teewinot’s global technology and intellectual property represent a breakthrough in the creation and delivery of cannabinoid based medicines.
Location: United States, Florida, Tampa
Employees: 11-50
Phone: 813-803-6300
Founded date: 2009
Investors 1
| Date | Name | Website |
| - | Emerald De... | emeraldman... |
Mentions in press and media 4
| Date | Title | Description |
| 05.05.2017 | Teewinot Life Sciences Raises $12.3M Series B Funding Round | Teewinot Life Sciences Corporation, a Tampa, Florida-based company involved in discovery, development and commercialization of cannabinoid-based therapeutics and in the biocatalytic production of cannabinoids, closed a $12.3m Series B fundi... |
| 02.05.2017 | Term Sheet — Tuesday, May 2 | PUTTING THE SILICON IN SILICON VALLEY Today we have another installment in Term Sheet’s series of interviews with dealmakers at the tech industry’s most active acquirers. Cisco is an acquisition machine, having done nearly 200 deals in its ... |
| 01.05.2017 | Teewinot Life Sciences Corp Raises $12.3M Series B | Teewinot Life Sciences Corporation (Teewinot), an industry leader in discovery, development and commercialization of cannabinoid-based therapeutics and the global leader in the biocatalytic production of cannabinoids, announced today that i... |
| 22.02.2017 | Cannabis Startups Raise $66.3m in 2016 as Canopy Leads 2017 with $300k Accelerator | Cannabis-related technology startups raised $66.3 million in venture capital investment in 2016, according to AgFunder’s 2016 AgTech Investing Report. Of the 27 deals captured in 2016, the vast majority were seed stage rounds. This is unsur... |